| Autor: |
Amaducci, Alexandra M., Campleman, Sharan L., Li, Shao, Karshenas, Dana L., Spyres, Meghan B., Farrugia, Lynn A., Kang, A. Min, Culbreth, Rachel E., Wax, Paul M., Brent, Jeffrey, Aldy, Kim, Acciani, Jennifer, Adeyeye, Elizabeth, Akpunonu, Peter, Albertson, Timothy, Algren, Adam, Archer, John, Atti, Sukhshant, Avera, Robert, Babu, Kavita |
| Předmět: |
|
| Zdroj: |
Journal of Medical Toxicology; Oct2023, Vol. 19 Issue 4, p313-340, 28p |
| Abstrakt: |
Since 2010, medical toxicology physicians from the American College of Medical Toxicology (ACMT) Toxicology Investigators Consortium (ToxIC) have provided reports on their in-hospital and clinic patient consultations to a national case registry, known as the ToxIC Core Registry. De-identified patient data entered into the registry includes patient demographics, reason for medical toxicology evaluation, exposure agents, clinical signs and symptoms, treatments and antidotes administered, and mortality. This thirteenth annual report provides data from 7206 patients entered into the Core Registry in 2022 by 35 participating sites comprising 52 distinct healthcare facilities, bringing the total case count to 94,939. Opioid analgesics were the most commonly reported exposure agent class (15.9%), followed by ethanol (14.9%), non-opioid analgesic (12.8%), and antidepressants (8.0%). Opioids were the leading agent of exposure for the first time in 2022 since the Core Registry started. There were 118 fatalities (case fatality rate of 1.6%). Additional descriptive analyses in this annual report were conducted to describe the location of the patient during hospitalization, telemedicine consultations, and addiction medicine treatments. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink